THPO, in turn, by stabilizing HIF-1α, induces VEGF-A dependent autocrine/paracrine loops, acting on VEGFR-2 expressing tumor, or on non-tumor cells that may affect HCC development and progression (Figure 10). Here, HIF1A is linked to neoplasm.